Arimidex Anastrozole (1mg) 30 tablets is an anti-estrogen medication used for the treatment of breast cancer in postmenopausal women. It works by reducing the growth of estrogen receptors in the breast, which helps to reduce the risk of developing advanced breast cancer.
Arimidex Anastrozole (1mg) 30 tablets is an aromatase inhibitor. It lowers estrogen levels by decreasing the production of androgen hormones, which are responsible for the symptoms of breast cancer. By inhibiting the aromatase enzyme, Arimidex Anastrozole (1mg) 30 tablets prevents the conversion of androgens (such as estrogen) to estrogen.
Some common side effects of Arimidex Anastrozole (1mg) 30 tablets can include:
Before starting Arimidex Anastrozole (1mg) 30 tablets, it's important to discuss your medical history with your doctor. He or she will likely perform certain tests to check for hormone imbalances or low levels of estrogen. Arimidex Anastrozole (1mg) 30 tablets may interact with other medications you are taking, including:
Arimidex Anastrozole (1mg) 30 tablets should be taken as advised by your doctor. The recommended dosage is one tablet every 4 to 6 weeks. In some cases, Arimidex Anastrozole (1mg) 30 tablets may take up to a year to show noticeable benefits. It's important not to exceed the maximum dosage for any given period of time without consulting your doctor.
Some of the side effects of Arimidex Anastrozole (1mg) 30 tablets can include:
Arimidex is a medication used to treat breast cancer. It belongs to a class of drugs called aromatase inhibitors and is available as an oral tablet.
Arimidex is metabolized primarily by the liver and excreted in urine.
Arimidex is designed to block the effects of estrogen on the breast tissue, preventing estrogen from attaching to this crucial hormone. Estrogen is vital for the development of breast cancer and is a key hormone in the growth and spread of breast cancer.
Arimidex is primarily used for treating breast cancer in postmenopausal women.
Arimidex may also be used off-label for other hormone receptor-positive breast cancers, such as hormone receptor-positive ovarian (tNBC) or hormone receptor-unknown (ER+) breast cancers.
The recommended starting dose of Arimidex for postmenopausal women is 0.5mg once daily.
For a lower starting dose of 0.5mg per day, the recommended starting dose is 0.5mg once daily.
For an initial dose of 1mg per day, start taking 0.5mg once daily as needed.
For a dose of 0.5mg once daily, the recommended starting dose is 1mg once daily.
For a dose of 1mg once daily, continue taking 0.5mg once daily.
The duration of treatment with Arimidex depends on the type of breast cancer being treated and the individual's medical history. The maximum recommended dose is 0.5mg per day.
Arimidex is generally well tolerated. Common side effects include:
Less common but more serious side effects may include:
Rarely, Arimidex can cause liver or kidney problems. If you experience any unusual symptoms while taking Arimidex, stop taking the medication and contact your healthcare provider.
Arimidex is contraindicated in the following cases:
Arimidex may also be contraindicated in women with a known hypersensitivity to any component of the medication. Women who have had a previous history of hypersensitivity reactions to an aromatase inhibitor should not take Arimidex.
Arimidex may not be safe in women who are pregnant, breastfeeding, or have liver problems. It is not recommended for women who are undergoing hormone therapy or menopause due to the risk of the medication entering the body's metabolic pathways. Arimidex may be harmful if administered during pregnancy. It is also not recommended for women who are trying to conceive because of the risk of the drug entering the body's metabolic pathways.
Arimidex should not be given to children under the age of 18 years without consulting their healthcare provider. It is also not recommended for children who have adrenal insufficiency due to the risk of adverse effects from adrenal insufficiency.
Arimidex may interact with certain medications, so it is important to inform your healthcare provider about all the medications you are taking.
Arimidex is contraindicated in people with a known hypersensitivity to any component of the medication.
It is not recommended for people who have liver disease due to the risk of the medication entering the body's metabolic pathways.
Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Medicare CardNo MedicareConcession
$19.95
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Keep taking this product if you have trouble breathing, tiredness, dry mouth, memory loss, fits or seizures, trouble sleeping, shaking, feeling tired, fainting, stomach pain, dizziness or lightheadedness, depression, stomach pain, feeling tired, slow or irregular heartbeat, headache, sweating, mouth or throat burning, feeling weak, blurred vision, fruity breath odour, jaundice (yellowing of the skin or eyes) or more likely, feel you areodies, allergic reactionHealthylife.auThis product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
This product is temporarily unavailable.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Republic of change◆Healthylife sells a few brand names:
name(s) only: Healthylife (anastrozole) 1mg 30 tablets (15 caplets) 0.15%(ichever is less) 25 tablets (15 caplets) 0.25%(ichever is greater) 50 tablets (15 caplets) 0.5mg(ichever is greater) 100 tablets (15 caplets) 125 caplets (15 caplets) 125 caplets (15 caplets) 150 caplets (15 caplets)
Brand: $10
Healthylife (anastrozole) 1mg 30 tablets (15 caplets) 0.15%(ichever is less) 25 tablets (15 caplets) 25 tablets (25 caplets) 50 tablets (15 caplets) 50 tablets (50 caplets) 100 tablets (15 caplets) 125 caplets (15 caplets) 125 caplets (15 caplets) 150 caplets (15 caplets) 150 caplets (15 caplets)
Listed here are only a few of the products offered by Healthylife. Product descriptions, logos, and geographical locations are available on the product packaging. Only aproximately 3% of the total product listings contains key information.
Additional information:
Medicare Advantage Scheme (as at 19/07/2024)
ReferencesZAVara: Zavamed (ara-imide-21-0014), ZAVara Prescription Only Medicine (as at 19/07/2024) Republic of changeDrug information: Republic of change Republic of changeUnited Kingdom (United States of America) ( Republic of)United States (India) ( Republic of)Rest of the world (India) ( Republic of)Russia (India) ( Republic of)Multinational pharmaceutical companies (as at 19/07/2024)</ traveller access-control dataMedication informationSwitzerland ( Switzerland) ( Rest of Europe)</ traveller access-control dataMedication informationU. S. ( India) ( Rest of Europe)</ traveller access-control dataMedication informationZVAara: Arimidex Anastrozole (anastrozole), manufactured by Healthylife, has been approved by the U. Food and Drug Administration (FDA) to be sold by Healthylife by an independent pharmacy. Healthylife has not demonstrated that it is legitimate or safe for use in the United States or Canada. Healthylife has not provided health information about Arimidex Anastrozole (anastrozole) or the generic version, and is not authorized to offer medical advice or treat health conditions outside the United States. Healthylife has not provided health information about ZAVara Prescription Only Medicine (or ZAVara), nor is it authorized to offer any medical advice or treat health conditions outside the United States.This study aimed to compare the efficacy of the combination of Arimidex with anastrozole, a specific aromatase inhibitor, in the treatment of hot flushes associated with the diagnosis of hot flushes in adolescents.
Keywords: Arimidex, anastrozole, aromatase inhibitor, hot flushes
The results of the study showed that the combination of Arimidex with anastrozole significantly increased the time to first attacks of hot flushes (8.2 minutes vs. 6.6 minutes, p = 0.001). Patients who were treated with Arimidex and anastrozole at the same time also improved their first attacks of hot flushes compared to the placebo group. The combination of Arimidex with anastrozole significantly improved the time to first attacks of hot flushes (6.3 minutes vs. 5.5 minutes, p = 0.001).
Study Design: This was a single-center, open-label, randomized, single-dummy, double-blind study, to compare the efficacy of the combination of Arimidex and anastrozole, a specific aromatase inhibitor, in the treatment of hot flushes associated with the diagnosis of hot flushes in adolescents.
The study was conducted at the National Asthma and Allergy Foundation of India (NAFAI) as a monotherapy (Table ).
Stade de France Pharmacy